Krystal Biotech (KRYS) PT Raised to $403 at TD Cowen
Tweet
Share
E-mailGet Alerts KRYS Hot Sheet
Price: $338.75 --0%
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 7 | New: 18
Rating Summary:
17 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 18 | Down: 7 | New: 18
Join SI Premium – FREE
TD Cowen analyst Ritu Baral raised the price target on Krystal Biotech (NASDAQ: KRYS) to $403.00 (from $306.00) while maintaining a Buy rating.
You May Also Be Interested In
- Goldman Sachs Downgrades Tsingtao Brewery Company Limited (168:HK) (TSGTF) to Neutral
- Beijer Ref AB (BEIJB:SS) PT Lowered to SEK170 at Barclays
- Apple (AAPL) PT Raised to $380 at Evercore ISI
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
